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Isolation and characterization of a murine resident liver
stem cell
A Conigliaro1, M Colletti1, C Cicchini1,2, MT Guerra2,3, R Manfredini4, R Zini4, V Bordoni2, F Siepi2, M Leopizzi5, M Tripodi*,1,2 and
L Amicone1
Increasing evidence provides support that mammalian liver contains stem/progenitor cells, but their molecular phenotype,
embryological derivation, biology and their role in liver cell turnover and regeneration remain to be further clarified. In this study,
we report the isolation, characterization and reproducible establishment in line of a resident liver stem cell (RLSC) with
immunophenotype and differentiative potentiality distinct from other previously described liver precursor/stem cells. RLSCs,
derived from fetal and neonatal murine livers as well as from immortalized hepatocytic MMH lines and established in lines, are
Scaþ , CD34, CD45, a-fetoproteinþ and albumin. This molecular phenotype suggests a non-hematopoietic origin. RLSC
transcriptional profile, defined by microArray technology, highlighted the expression of a broad spectrum of ‘plasticity-related
genes’ and ‘developmental genes’ suggesting a multi-differentiative potentiality. Indeed, RLSCs spontaneously differentiate into
hepatocytes and cholangiocytes and, when cultured in appropriate conditions, into mesenchymal and neuro-ectodermal cell
lineages such as osteoblasts/osteocytes, chondrocytes, astrocytes and neural cells. RLSC capability to spontaneously
differentiate into hepatocytes, the lack of albumin expression and the broad differentiative potentiality locate them in a pre-
hepatoblast/liver precursor cells hierarchical position. In conclusion, RLSCs may provide a useful tool to improve liver stem cell
knowledge and to assess new therapeutic approaches for liver diseases.
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Introduction
The identification, isolation, in vitro expansion and therapeutic
use of stem cells from various tissues represent the greatest
current challenges in tissue engineering and regenerative
medicine. Up to date, formidable progresses in handling
hematopoietic, mesenchymal1,2 and simple epithelia stem
cells3 have been made, and therapeutic protocols aiming at
the repopulation of depleted bone marrow, the regeneration
of ischemic myocardium4 and the reconstitution of damaged
corneal epithelium5,6 are already available. On the other hand,
the possibility to engineer many other tissues, in particular
complex epithelia, is still very limited. Successful approaches
for stem cells utilization have been substantially based on
empirical attempts to identify specific cell markers, anatomical
compartments for cell isolation, appropriate conditions for
in vitro culture and in vivo cell transfer.
In the case of liver, the ability of fully differentiated
hepatocytes to give rise in vivo to cellular progeny that
replace cell loss is well known. The ‘staminal capability’ of
differentiated hepatocyte has encouraged the development
of hepatocyte transplantation protocols that, unfortunately,
yielded only partially effective therapeutic benefits.7 When
hepatocyte proliferation is impaired, the expansion of a limited
compartment of progenitor cells, the oval cells, becomes
recognizable.8 This mix population of cells expresses markers
common to hepatocytes and cholangiocytes and gives rise
to both liver epithelial cell lineages.9 Similarly, bipotential
precursor cells, able to differentiate and colonize diseased
liver in animal models, have been isolated from rodent and
human livers.10–12 Other extra and intra-hepatic precursor/
stem cell compartments have also been proposed. The
excitement on an ‘extra-liver’ hepatic stem cell, derived from
studies showing trans-differentiation ability of bone marrow-
derived hematopoietic stem cells into hepatocytes,13–15 has
been narrowed by its limited contribution to liver regeneration
and by data highlighting as transplanted cells, observed in the
recipient liver, were the product of cell fusion rather than trans-
differentiation.16–18 Regarding the ‘resident’ liver stem cell,
two recent interesting reports describe pluripotent progenitor
populations isolated from fetal (human fetal liver multipotent
progenitor cell, hFLMPC)19 and adult (human liver stem cell,
HLSC)20 livers. The HLSCs, proposed as mesenchymal liver
population, and the hFLMPCs, proposed as mesenchymal-
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epithelial transitional cells, displayed the ability to differentiate
into hepatocyte and cholangiocyte as well as into several
mesenchymal lineages.
We have previously characterized and immortalized bi-
potential precursor cell line (Palmate cells) isolated from
immortalized non-tumorigenic hepatocytic cell lines (MMH)
derived from embryonic livers of cyto-Met transgenic
mice.10,21,22 On the basis of this evidence, several successful
attempts to isolate and manipulate liver bipotential cells from
many mouse inbred strains have been reported.11,23 Con-
sidering that an immortalized cell line is an invaluable tool for
in vitro studies of molecular mechanisms controlling stem cell
maintenance and differentiation, we aimed at the isolation and
establishment in line of a resident liver stem cell.
Here we describe how non-tumorigenic stable stem cell
lines are reproducibly obtainable from murine liver explants at
various stages of development. These cells, named RLSCs
from resident liver stem cells, in their undifferentiated state,
display a typical stemness expression profile, self-renewing
capability and a multilineage differentiation potentiality. We
showed that RLSCs, under appropriate culture conditions,
give rise to progeny that expresses specific markers for
polarized hepatocytes, cholangiocytes, osteoblasts, chondro-
cytes and neural cells.
Results
Derivation and establishment of RLSCs from liver
explants. Primary cultures were prepared from livers of
wild type embryos 14 days post coitum (dpc) (wtE14), cyto-
Met transgenic embryos 14 dpc (MetE14) and cyto-Met
transgenic mice 6 days after birth (MetNBD6). Table 1
summarizes the cell events obtained. Out of seven
Table 1 Cumulative evaluation of RLSCs derivation
Primary
cultures
Number of
colonies
Clones with palmate
morphology
Time for colony
emergence
Immortalized
RLSC lines
Efficiency of tumor
formation in nude mice
WT E14 25 4 7 weeks 3 o1106
Met E14 30 4 4 weeks 3 o1106
Met NB-D6 15 2 4 weeks 1 o1106
The table summarizes the immortalization events obtained from primary cultures of wtE14, MetE14 and MetNBD6 livers. In each case the primary cultures were
seeded at high density in a collagen treated 10 cm dish
Figure 1 Cell surface phenotype of RLSCs. (a) Phase-contrast micrograph of a representative RLSC line showing the typical ‘palmate’ morphology. (b) FACS analysis for
the indicated surface molecules. Filled curves: specific antibody staining; unfilled curves: isotype control antibody. Data are representative of three separate experiments
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established RLSC lines, three (WTE14/1, MetE14/3 and
MetNBD6/1) have so far been kept in culture for more than
12 months and from them individual clones, by limiting
dilution (see Materials and Methods), were derived (Figure 1a).
Three clones, one for each line, were immunophenotyped as
Sca1þ , CD45, CD34, CD117 and CD133 (Figure 1b)
and used for further described characterization.
RLSC differentiation toward liver epithelial cell line-
ages. Firstly, RLSCs were tested for their capability to
differentiate into liver epithelial cell lineages both in vitro and
in vivo. To ascertain the in vitro ability to differentiate along the
hepatocytic lineage, the three different RLSC clones were
repeatedly grown to confluence and subcultured in
Hepatocyte Conditions (HC). After an average of six
passages, RLSCs acquired a hepatocyte-like morphology
(cuboidal and tightly packed) independently of cell confluence.
The morphological changes corresponded to the acquisition
of epithelial polarization and hepatocyte differentiation as
revealed by the immunofluorescence analysis. Figure 2a
shows that the polarity markers Zonula Occludens 1 (Zo-1)
and E-cadherin (E-cad) are localized to the membrane and
that Albumin and Hepatocyte Nuclear Factor (HNF)-4a are
expressed in more than 90 percent of the cells. RT-PCR
analysis extended the observations to other liver enriched
transcriptional factors and liver products (Figure 2b).
Figure 2 RLSCs differentiate toward hepatic lineages. (a) Phase-contrast micrographs and confocal immunofluorescence analysis for the polarization markers E-cad and
Zo1, for the liver product Albumin and for the hepatocyte-specific transcription factor HNF4alpha, of WT E14/1clone cultured in basal conditions (BC) and in hepatocyte
conditions (HC) for 21 days. Nuclear staining was performed with toppro3. Similar results have been obtained with the other two clones. (b) Comparative RT-PCR analysis, for
the indicated liver specific transcriptional factors and products, of RLSCs cultured in BC and HC for 21 days and, as control, of MMH-D3 line. (c) Immunohistochemical findings
(staining for Albumin and CK7) of the engineered hepatic-like tissue obtained 60 days after RLCSs subcutaneous transplantation: the albumin-positive cells form epithelial
trabeculae while CK7 positive/albumin negative cells delimit empty spaces that recall bile ducts. Nuclear staining was performed with ematossilin
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To test in vivo the capability to differentiate along the
hepatic lineages, RLSCs were injected into neovascularized
subcutaneous cavities opportunely prepared in nude mice.
As shown in Figure 2c, these cells differentiate along both
parenchymal liver lineages, acquiring a striking spatial
organization with albumin-positive cells recalling the typical
liver epithelial trabeculae and CK-7 positive cells defining bile
duct-like structures. Remarkably, the expressions of albumin
(hepatocyte marker) and CK7 (cholangiocyte marker) were
mutually exclusive.
Gene expression profile. To define molecular phenotype of
the RLSCs, we assessed the transcriptome profile using
Affymetrix Mouse430_2 GeneChip array. For this analysis,
we chosen MetE14/3 and the WTE14/1 RLSC lines. The
expression profiles were compared to that of the previously
characterized hepatocytic differentiated cell line, MMH-D3.21
All the data have been deposited in the Gene Expression
Omnibus MIAME compliant public database, at http://
www.ncbi.nlm.nih.gov/geo (Table S1 of Supplementary
Data). Using DAVID TOOL 2.1 b, we assessed which GO
categories were significantly modulated. As detailed in
Table S2 of Supplementary Data, many genes belonging to
biological process GO categories, such as ‘establishment
and/or maintenance of chromatin architecture’, ‘DNA
packaging’, ‘chromatin assembly or disassembly,’ were
significantly upregulated in RLSCs. As reported in Table 2
(chromatin remodeling genes), the chromatin regulators
belonging to the SWI/SNF ATPase family Smarcd3, a
helicase of the snf2/rad54 family (Chd3), a deacetylase
(Sirt1) and the deacetylase interactor Sap18, a DNA methyl-
transferase (Set7) and two regulators of chromatin assembly
and nuclear organization (Cbx2, Chc1l) exhibited an
upregulated expression in RLSCs. Concerning genes
belonging to tissue development GO categories, while
those controlling the endoderm are expressed in both cell
lines, GO categories involved in other tissue development,
such as ‘skeletal development’, ‘nervous system
development’, ‘muscle development’, ‘embryonic
development’ and ‘cartilage development,’ were
upregulated in RLSCs (see Table S2 in Supplementary
Data). As shown in Table 2 (Stem cell and differentiation
markers), the brain specific transcription factors Ebf3 and
Zfp207, the transcription factor Twist2, implicated in
osteoblastic differentiation and the receptor for WNT
proteins Fzd1, involved in chondrocyte differentiation,
displayed an upregulation in RLSCs. Moreover, Table 2
shows as genes considered hallmarks of embryonal and
adult stem cells, such as Bmi1, Sca1, Notch1, Hoxa10,
Hoxa9, Meis1 and, surprisingly, markers specific for all of
the three endodermal (Foxa1), mesodermal (CNN1) and
ectodermal (nestin, Enc1) stem cells were upregulated in
RLSCs. We next validated and extended the significance of
microArray data by performing a quantitative RT-PCR
analysis on a subset of genes for all of the three clones. As
shown in Figure 3, we found a coherent expression pattern
among the three RLSC clones with respect to control MMH-
D3 cells. Overall, these data suggest that the capability of
RLSCs to differentiate along the hepatic lineages is based
on the expression of a broad number of ‘plasticity related
genes’. Moreover, the RLSCs were found to express a
number of genes related to multidifferentiative programs thus
suggesting that their plasticity may not be restricted to the
hepatic lineages. This prompted us to manipulate them
toward other cell lineages. By means of soluble factors and
culture conditions mutuated from the literature, we tested the
capability of the three RLSC lines to differentiate along the
osteoblastic, chondrocytic and neuronal lineages.
Table 2 Genes increased in RLSCs belonging to chromatin remodeling and stem cell marker categories
ProbeSet ID Gene title Gene symbol LocusLink Met E14/3 RLSCs
vs MMH-D3 SLR
WT E14/1 RLSCs
vs MMH–D3 SLR
Chromatin remodeling genes
1434116_at Chromobox homolog 2 (Drosophila Pc class) Cbx2 12416 1.1 1.8
1416389_a_at Chromosome condensation 1-like Chc1l 105670 1.8 2.3
1428466_at Chromodomain helicase DNA-binding protein 3 Chd3 216848 1.7 1
1449480_at Sin3-associated polypeptide 18 Sap18 20220 1.3 1.3
1435437_at SET domain-containing protein 7 Set7 73251 2.3 1.6
1418640_at Sirtuin 1 ((silent mating type information regulation 2,
homolog) 1 (S. cerevisiae)
Sirt1 93759 1 1
1418467_at SWI/SNF related, matrix associated, actin-dependent
regulator of chromatin, subfamily d, member 3
Smarcd3 66993 5.8 4.3
Stem cell and differentiation markers
1428349_s_at Early B-cell factor 3 Ebf3 13593 3 6.2
1448925_at Twist homolog 2 (Drosophila) Twist2 13345 5.1 1.5
1437284_at Frizzled homolog 1 (Drosophila) Fzd1 14362 2.2 3.8
1438294_at Spinocerebellar ataxia 1 homolog (human) Sca1 20238 2.4 1.1
1418634_at Notch gene homolog 1 (Drosophila) Notch1 18128 1.3 1.2
1448733_at B lymphoma Mo-MLV insertion region 1 Bmi1 12151 1.6 1.3
1431475_a_at Homeo box A10 Hoxa10 15395 2 1
1455626_at Homeo box A9 Hoxa9 15405 2.9 1
1450992_a_at Myeloid ecotropic viral integration site 1 Meis1 17268 2.2 1
1418496_at Forkhead box A1 Foxa1 15375 8.1 1
1417917_at Calponin 1 Cnn1 12797 4.2 1.5
1420965_a_at Ectodermal-neural cortex 1 Enc1 13803 1.1 2
1449022_at Nestin Nes 18008 5.9 1.9
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RLSC differentiation toward osteoblastic lineage. RLSCs
were induced to differentiate along the osteoblastic lineage
under Osteogenic Conditions (OC). Interestingly, within 14
days OC induced a change in cellular morphology parallel with
the induction of osteoblast/osteocyte specific genes, as
revealed by RT-PCR analysis for Osteocalcin, Parathormon
receptor, Periostin, Osteopontin, Alkaline Phospatase 2 and
Ibfp (Figure 4a); moreover, 70–80 percent of cells became
positive for Alkaline Phosphatase staining and, at longer time
(3 weeks), underwent CaPO4 mineralization process,
revealed by Red Alizarin staining (Figure 4b). These data
provide evidences for the osteoblast/osteocyte differentiative
potentiality of RLSCs.
RLSC differentiation toward chondrocyte lineage. We
next induced RLSCs to differentiate along the chondrocyte
lineage under chondrogenic conditions (CC), chosen in
accord with standard protocols for culture of primary
chondrocytes. Cells, within 21 days in CC, form a
suspended compact micromass ‘per se’ recapitulating the
process of chondrogenesis and chondrocyte maturation.
To unveil a coherent molecular phenotype, pellets were
analyzed for transcripts and products of chondrocyte specific
genes. RT-PCR analysis demonstrated the Aggrecan and
Collagen-II expression (Figure 4c); immunohistochemical
and histochemical analyses showed a 30 percent of
chondrocyte-like cells expressing collagen II (Figure 4d)
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Figure 3 RLSCs transcriptional profile. Validation of MicroArray gene expression data by real-time RT-PCR (qRT-PCR). The analysis for the indicated genes was
performed on RLSCs (WTE14/1, MetE14/3 and MetNBD6/1 clones) cultured in basal conditions and on MMH-D3. The RT-PCR results were calculated by Delta-Delta CT
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lodged in lacunae embedded in Alcyan Blu positive matrix
(Figure 4e). These data provide evidence for the chondrocyte
differentiative potential of RLSCs.
RLSC differentiate toward neural cell lineages. We next
induced RLSCs to differentiate along the neural cell lineages
under neurogenic conditions (NC) mutuated from neural
Figure 4 RLSCs differentiate toward osteoblast/osteocyte and chondrocyte lineages. (a) RT-PCR analysis for osteoblast/osteocyte-specific markers. RLSCs cultivation
for 14 days in osteogenic conditions (OC) induced the transcription of the indicated osteoblast/osteocyte specific genes. As control, the analysis was performed on
undifferentiated RLSCs cultured in basal conditions (BC) for the same time. (b) Histochemical analysis for osteoblast/osteocyte-specific markers. MetNBD6/1 clone cultivated
for 14 days in OC became positive for alkaline phosphatase staining; RLSCs cultivated for 21 days in OC underwent CaPO4 mineralization process evidenced by Red Alizarin
staining. As control, the analyses were performed on RLSCs cultured in BC for the same time. Similar results have been obtained with the other two clones. (c) RT-PCR
analysis for chondrocyte-specific markers. MetNBD6/1 clone cultivation for 14 days in chondrocyte conditions (CC) induced the transcription of the indicated chondrocyte-
specific genes. As control, the analysis was performed on undifferentiated RLSCs cultured in BC for the same time. Similar results have been obtained with the other two
clones. (d and e) Immunohistochemical and histochemical analyses for chondrocyte-specific markers. MetNBD6/1 clone cultured as micro-pellets showed chondrocyte-like
cells positive for collagen type II and lodged in lacunae (arrows) embedded in Alcyan Blu positive matrix. Similar results have been obtained with the other two clones
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stem cells culture and differentiation protocols. In particular,
for neurogenic induction, RLSCs were cultured as spheres
and then seeded on collagen, where cells grew as
monolayer, or on Matrigel, where cells spread out
(Figure 5a). Both conditions caused upregulation of neuron-
related genes, although with differences. The RT-PCR
analysis, in fact, revealed that cells grown on matrigel
downregulated the neuronal precursor markers Nestin and
NPas1 and upregulated the neuronal specific genes Fgf9
and NeuroD2, while cells grown on collagen coexpress the
neuronal specific genes Ngn1 and NeuroD2 with Nestin and
NPas1 (Figure 5b). Finally, to further induce the neuronal
differentiation, spheres were mechanically dissociated and
cells cultivated at low density on matrigel. After 14 days,
50–60 percent of cells were found positive for the astrocyte
marker Glyal Fibrillar Acid Protein (GFAP) and after 21 days,
20–30 percent of cells, for b III tubulin (Figure 5c). These
data provide evidence for initial neural differentiation of
RLSCs. Notably, RLSCs derived from liver explants of a
MetNBD6 mouse failed to differentiate along neuro-
ectodermal lineages.
Discussion
In this work, we describe the reproducible isolation and
characterization of resident liver stem cells with self-renewal
capability and competence to differentiate into hepatic
parenchymal cells and, when instructed by specific culture
conditions, into mesenchymal and neuroectodermal lineages.
These cells, established in several non-tumorigenic clonal
cell lines, differ from other previously described liver stem/
precursor cells. RLSCs, in fact, do not express albumin, a liver
product normally present in other liver precursor cells, such
as hepatoblasts and oval cells, as well as in the recently
described human liver precursor/stem cells, HLSCs.20 More-
over, RLSCs express the liver tissue-specific protein a-
fetoprotein (aFP), which is considered a marker of early
hepatocyte precursors and is not expressed in hepatic
mesenchymal stem cells and in the recently reported human
fetal liver multipotent progenitor cells, hFLPMs.19 RLSCs do
not express CD45 and CD34 hematopoietic stem cell
markers, suggesting that they do not derive from circulating
hematopoietic cells. The transcriptional profile of RLSCs
mirrors and probably explains their plasticity. Undifferentiated
RLSCs coexpress a wide range of mesenchymal (e.g.
calponin 1), endodermal (e.g. FoxA1 and aFP) and neuroec-
todermal (e.g. nestin) stem cell markers together with several
plasticity-related genes (chromatin remodeling genes) widely
considered crucial for the activation of stem cell genetic
programs.24–26
RLSCs differentiate into hepatic epithelia spontaneously.
Notably, HCs being free of differentiative cytokines (e.g.
Figure 5 RLSCs differentiate toward the neuro-ectodermal cell lineages. (a) Phase-contrast micrographs of MetE14/3 clone, cultured as neurospheres and subsequently
seeded on collagen, grew as monolayer and on matrigel, where the cells spread out. (b) RT-PCR analysis for neuronal-specific markers. MetE14/3-spheres cultivated on
Matrigel downregulated the neuronal precursor markers Nestin and NPas1 and upregulated the neuronal-specific genes Fgf9 and NeuroD2; MetE14/3-spheres cultivated on
collagen upregulate the neuronal-specific genes Ngn1 and NeuroD2. As control, the analysis was performed on MetE14/3 cultured on BC. Similar results have been obtained
with WTE1 4/1. (c) Immunostaining for the neural markers of MetE14/3-spheres mechanically dissociated and cultivated at low density in matrigel. The cells became positive
for the astrocyte marker GFAP after 14 days of culture and after 21 days for b III tubulin. Similar results have been obtained with WTE14/1
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Oncostatin-M and HGF) do not induce hepatocyte and/or
cholangiocyte markers in CD34þ bone marrow-derived cells
(data not shown). This intrinsic differentiation program
distinguishes RLSCs from liver mesenchymal and haemato-
poietic stem cells.
RLSCs differentiate into chondrocytes and osteoblast/
osteocytes, as determined by observations, at morphological,
transcriptional and immunohistochemical levels highlighting
the acquisition of tissue-specific markers.
Interestingly, RLSCs grow as spheres and express typical
markers of neuronal and astrocytic cells. In fact, RLSCs
respond to specific culture conditions with a morphological
transition that parallels the expression of astrocyte-specific
GFAP and neuron-specific b III tubulin, expressed in different
cells in a mutually exclusive fashion. Even if the cell
morphology suggests only an initial neural differentiation
process, we believe that the observed neurogenic behavior
represents a novel trait of plasticity attributed to a resident liver
stem/precursor cell. While all the other differentiated pheno-
types measured and described were identical for the three
RLSC lines, regardless of the genotype and the stage of
isolation, the neurogenic potentiality was not found in RLSCs
isolated from the liver of days 6 newborn mouse, suggesting a
more strict meso-endodermal commitment of RLSCs after
birth.
Finally, the RLSC self-renewal and asymmetric division
capability was supported not only by the mere observation of
an expansion and long-term maintenance of undifferentiated
cells, but also by the possibility to re-isolate them from
differentiated MMH lines21 maintained in culture for more than
40 populations (data not shown).
In conclusion, RLSCs may contribute to elucidation of many
aspects of stem cell biology, liver development and hepato-
cyte differentiation. In particular, they provide an in vitro
system for the identification of critical microenviromental
factors involved in stem cell maintenance, expansion and
lineage-specific differentiations.
Materials and Methods
Animals. Mice (Charles River Laboratories, Lecco, Italy) received human care
and the procedures involving them were conducted in conformity with the criteria
outlined in the ‘Guide for the Care and Use of Laboratory Animals’ prepared by the
National Academy of Sciences and published by the National Institutes of Health
(NIH publication 86–23 revised 1985).
Primary hepatocyte culture. Primary cultures were performed in accord
with previously described protocol (Amicone, 199721) with some modifications.
Briefly, livers from 14.5 dpc embryos and 6 days newborns were dissected,
mechanically dissociated using a Potter glass homogenizer and plated at high
density on collagen I (Transduction Laboratories, Lexington, UK) coated dishes
(Falcon-BD, Franklin Lakes, NJ, USA) in RPMI-1640, supplemented with 10% fetal
bovine serum (FBS) (Gibco, Carlsbad, CA, USA), 50 ng/ml epidermal growth factor,
30 ng/ml insulin like growth factor II (PeproTech Inc, Rocky Hill, NJ, USA), 10mg/ml
insulin (Roche, Mannheim, Germany), 2 mmol/l L-glutamine, 100m/mL penicillin and
100mg/ml streptomycin (Gibco). After 12–24 h, the cultures were washed to remove
all unattached cells, including red blood cells and the medium replaced. The cultures
were maintained without transfer for several weeks with medium replacement twice
a week. Within 4 weeks of culture the majority of cells died, and within 6 weeks
colonies with distinct cell morphology became visible; cloning rings were placed
around cell colonies allowed to transfer the clones with palmate morphology that
were subcultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10%
FBS (basal medium) on collagen I-coated dishes and frozen after B50 cell
generations. Subsequently, to obtain clonal cell lines, we performed limiting dilution
seeding cells in a microtitration plate at a concentration of 0.1 cell per well1.
Passages are calculated from initial thawing.
RNA extraction and Microarray data analysis. Total RNA from each
sample was extracted using RNeasy Mini Kit (Qiagen, Valencia, CA, USA) following
the protocol supplied by the manufacturer. Disposable RNA chips (Agilent RNA
6000 Nano LabChip kit, Agilent Technologies, Waldbrunn, Germany) were used to
determine the concentration and purity/integrity of RNA samples using Agilent 2100
Bioanalyzer.
One-cycle target labeling assays, as well as the Affymetrix Mouse430_2
GeneChip arrays hybridization, staining and scanning, were performed using
Affymetrix standard protocols (Affymetrix, Santa Clara, CA, USA).
Briefly, biotin-labeled target synthesis was performed, starting from 5 mg of total
cellular RNA, according to the protocol supplied by the manufacturer (Affymetrix,
Santa Clara, CA, USA). Labeled cRNA was purified using Affymetrix GeneChip
Sample Cleanup Module and fragmented (15mg) as described in the Affymetrix
GeneChip protocol. Disposable RNA chips (Agilent RNA 6000 Nano LabChip kit,
Agilent Technologies, Waldbrunn, Germany) and Agilent 2100 Bioanalyzer were
used to determine the cRNA concentration/quality as well as to optimize the cRNA
fragmentation.
The fragmented cRNA was then hybridized to an identical lot of Affymetrix
Mouse430_2 GeneChip arrays for 16 h. GeneChips were washed and stained using
the instrument’s standard Eukaryotic GE WS2v5 protocol, using antibody-mediated
signal amplification. GeneChip were finally scanned using the Affymetrix GeneChip
scanner 3000, enabled for high-resolution scanning.
The Gene Chip Operating Software (GCOS) absolute analysis algorithm was
used to determine the amount of a transcript mRNA (Signal), while the GCOS
comparison analysis algorithm was used to compare gene expression levels
between two samples.
Present genes were selected as the sequences showing the Detection call ‘P’
and Signal 4100 at least in one sample. Differentially expressed genes were
selected as the sequences showing a Change call ‘I’ or ‘D’ and Signal Log Ratio41
or o1 in the pair-wise comparisons between RLSCs and MMH-D3 cells. The
gene list passing this filter was selected as ‘changing genes’.
DAVID TOOL 2.1 Beta (http://david.abcc.ncifcrf.gov/) was used to examine
selected lists of genes to identify over-representation of functional classes
accordingly with gene-ontology (GO) classification.
RNA extraction, reverse transcription, PCR and real time
quantitative PCR (RT-qPCR). Total RNA was extracted from cultured
cells using an RNA extraction kit (NucleoSpins RNA II, Machery-Nagel, Germany)
according to the manufacturer’s instructions. Single-stranded cDNA was obtained
by reverse transcription of 1 mg of total RNA using MMLV-reverse-transcriptase
(Promega, Italia). cDNA was amplified by PCR using GoTaq enzyme (Promega).
RT-qPCRs were performed using BioRad-iQ-iCycler with SYBR green fluorophore;
the reactions were carried out using iQt SYBRs Green Supermix (BioRad,
Hercules, CA, USA); 40 ng of cDNA was used as template and cycling parameters
were 951C for 3 min, followed by 45 cycles of 951C for 30 s, 601C for 1 min, 721C for
30 s, 601C þ 0.51C for 10 min. Fluorescence intensities were analyzed using the
manufacturer’s software, and relative amounts were obtained using the 2–DDCt
method. For a list of specific primers, see Table 3.
Differentiative culture conditions. All differentiation protocols were
performed with three different RLSC lines. The RLSCs hepatocyte differentiation
occurs in RPMI-1640, supplemented with 10%FBS, 50 ng/ml EGF, 30 ng/ml IGF-II,
10mg/ml insulin and antibiotics on collagen-I coated dishes (hepatocyte conditions,
HC). Cells were repeatedly grown to confluence and subcultured for 21 days.
Medium was changed every 2 days. The RLSCs osteoblast/osteocyte differentiation
occurs in DMEM, 10%FBS, 0.1mM/l dexamethasone, 100mg/ml ascorbic acid,
10mM b-glycerol-phosphate (Sigma-Aldrich, St. Louis, MO, USA), 1 mM vitamin A
acid (Fluka Riedel-de Hae¨n, Seelze, Germany) on collagen-I coated dishes
(osteogenic conditions, OC). 5000 RLSCs/cm2 were seeded and cultured for 3
weeks. Medium was replenished every 3 days. Osteogenesis was assessed by
Alkaline-phosphatase (after 14 days of culture) and red-Alizarin (after 21 days of
culture) stainings, in accord with standard protocols. The RLSCs chondrocyte
differentiation occurs in the following chondrogenic conditions (CC): 5 105
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Table 3 List of oligonucleotides used in PCR and in qRT-PCR analyses
Gene Oligos RT-PCR Accession no.
b-actin For 50-ATGGATGACGATATCGCTGCG-30 NM_007393
Rev 50-ATCTTCATGAGGTAGTCTGTCAGG-30
Liver differentiation
HNF1 For 50-CCAACAAGATGTCAGTG-30 NM_000544
Rev 50-GCTGGTGAGAGTGTTGATGC-30
HNF3b For 50-ACATGTTCGAGAACGGCTGC-30 U04197
Rev 50-TGAAGGCTGAATGGTGCTCG-30
HNF4 For 50-ACACGTCCCCATCTGAAG-30 NM_008261
Rev 50-CTTCCTTCTTCATGCCAG-30
E-caderin For 50-CAAGCTGGAGACCAGTTTCC-30 NM_009864
Rev 50-CAGAGGTGAGCACACTGATG-30
Transthyretin (TTR) For 50-CTGGACTGGTATTTGTGTCT-30 NM_013697
Rev 50-TTGGCTGTGAAAACCACATC-30
Albumin For 50-GTGACAAATCCCTTCACACTC-30 NM_009654
Rev 50-GTCCTCAACAAAATCAGCAGC-30
Got1 For 50-AGCCTCAACCACGAGTACCT-30 NM_010324
Rev 50-ATCTGCTTCCACTGCTCTGG-30
Pepck For 50-GACAACTGTTGGCTGGCTC-30 NM_011044
Rev 50-GCCCAGGATCAGCATATGC-30
Eph For 50-TGGCTTCAACTCCAGCTACC-30 NM_010107
Rev 50-TTCTGACTTGGTCCAGGTGG-30
a-Fetoprotein (a´ FP) For 50- TCGTATTCCAACAGGAGG-30 NM_007423
Rev 50-GAAATCTCACATGGACATC-30
Chondrogenic differentiation
Collagen II For 50-GATGGCTCTAATGGAATCCC-30 NM_031163
Rev 50-CATCGCCATAGCTGAAGTG-30
Aggrecan For 50-GTCTGGAGTAGAAGCTTCAG-30 NM_007424
Rev 50-GTAACAGTG ACCCTGGAAC-30
Osteogenic differentiation
Osteocalcin For 50-AGGACCCTCTCTCTGCTCAC-30 NM_04142
Rev 50-GTAGATGCGTTTGTAGGCGGT-30
Pthr For 50-GGGCACAAGAAGTGGATCAT-30 NM_011199
Rev 50-GTCCCTGAGACCTCGGTGTA-30
Periostin For 50-AGGTCTCCAAGGTCACAAAG-30 NM_015784
Rev 50-TGGACCCAGTCACAATGATG-30
Osteopontin For 50-CAGAGAGCGAGGATTCTGT-30 NM_009263
Rev 50-CCAGACTTGGTTCATCCAG-30
Akp2 For 50-GACAGCAAGCCCAAGAGACC-30 NM_007431
Rev 50-AGAGCGAAGGGTCAGTCAGG-30
Ibsp For 50-GGAGACTTCAAACGAAGAGG-30 NM_008318
Rev 50-GTGGTTCCTTCTGCACCTG-30
Neuronal differentiation
Nestin For 50-AGACACCTGGAAGAAGTTCC-30 NM_016701
Rev 50-GGATCATCAGGGAAGTGGTC-30
Neurogenin1 For 50-ACCTGCATCTCTGATCTCG-30 NM_010896
Rev 50-GATGTAGTTGTAGGCGAAGC-30
Npas1 For 50-ACTGGTTACTACCGTTGGCT-30 NM_008718
Rev 50-ATACATCAGGCTCAACTCCG-30
NeuroD2 For 50-CGAGAAGATTCCTCTTCTCC-30 NM_010895
Rev 50-ACAGAGTCTGCACGTAGGT-30
NeuroD4 For 50-CGGAACCTTAACTGAAGAGC-30 NM_007501
Rev 50-GCTGTGGACAGAGATAGTAG-30
Fgf9 For 50 -TGGATATACCTCGCCTAGTG-30 NM_013518
Rev 50-TTTCTGGTGCCGTTTAGTCC-30
Gene Oligos RT-PCR Accession no.
b-actina For 50-ACCACACCTTCTACAATGAG-30 NM_007393
Rev 50- AGGTCTCAA ACATGATCTGG-30
Smarcd3 For 50- ACAGTAAGATCCATGAGACGA-30 NM_025891
Rev 50- CACATCTGTCATCACCTTGAG-30
Foxa1 For 50- GACCCGTGCTAA ATACTTCC-30 NM_008259
Rev 50- TATGTGGTTGGTTTGGTGTG-30
Nestin For 50- ATCCAGAGTTACCAAAGCCT -30 NM_016701
Rev 50- GTCTCCAGTGATTCTATGTTCTC-30
Cnn1 For 50- AAACAAGAGCGG AGATTTGAG-30 NM_009922
Rev 50-CCAGTTTGGGATCATAGAGG-30
Fzd1 For 50- GGCACTAAGAAAGAAGGCTG-30 NM_021457
Rev 50-ATGGAAATACTGTGAGTTGGC-30
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trypsinized RLSCs were transferred into a 15-ml polypropylene tube and centrifuged
at 1000 r.p.m. for 5 min. The pellet was cultured in chondrogenic medium for 3
weeks. Chondrogenic medium: DMEM, 1% FBS, 37.5mg/ml ascorbic acid, ITS-
premix (BD Biosciences, Bedford, MA, USA) and 10 ng/ml transforming-growth-
factor-b1 (PeproTech). The medium was changed every 3 days. Pellets were fixed
and sections were stained with alcian blue and immunostained for collagen-type-II
(Mouse anti-collagen type-II monoclonal antibody, Chemicon International Inc.,
Temecula, CA, USA). The RLSCs neural differentiation occurs in the following
neurogenic conditions (NC): cells were plated in untreated tissue culture dishes
(TechnoPlastic-Products, Trasadingen, Switzerland) in the Advanced-DMEM-F12
medium (Gibco) supplemented with retinoic acid 1ng/ml (Fluka Riedel-de Hae¨n,
Seelze, Germany), EGF 20 ng/ml, bFGF 10 ng/ml (PeproTech) and eparin 5ng/ml
(Sigma). In these conditions, RLSCs proliferate like spheres. After 6 days these
were mechanically dissociated into a single cell suspension and plated at low
density on 35 mm Petri dishes coated with Matrigel-Matrix (Becton-Dickinson,
San Jose, CA, USA) or with collagen type-I. To induce the differentiation, EGF and
bFGF were replaced by 5% FBS for 14 days. The medium was changed every
2 days.
Immunofluorescence and FACS. For indirect immunofluorescence
analysis, cells were grown on collagen-I or matrigel-coated dishes, fixed and
treated as described previously.27 The antibodies were used at the following
dilutions: mouse monoclonal anti-ZO-1 antibody 1/30 (Zymed-Laboratories, South
San Francisco, USA); mouse monoclonal anti-E-cad antibody 1/100 (Transduction
Laboratories, BD Biosciences Pharmingen, Palo Alto, CA, USA); rabbit polyclonal
anti-Albumin 1/200 (Novus Biologicals Inc. Littleton, CO, USA), goat polyclonal anti-
HNF4-alpha 1/100 (c-19) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit
polyclonal anti-GFAP 1/300 (DakoCytomation, Glostrup, Denmark), mouse
monoclonal anti Neuronal Class III b-Tubulin 1/500 (Covance, Berkeley, CA,
USA). Secondary antibodies (Alexa-Fluor 488 diluted 1:1000) were from Molecular
Probes, Eugene, OR, USA. Preparations were examined with a Zeiss Axiophot
microscope and with a Leica TCS2 confocal microscope. Flow cytometry was
undertaken using a FACS Calibur (Becton Dickinson). Antibodies for flow cytometry
analysis: monoclonal antibodies FITC-conjugated anti-CD34 and anti-Sca1; PerCp-
conjugated anti-CD90, PE-Cy5-conjugated anti-CD45 and PE-conjugated anti-
CD117 were all purchased from BD PharMingen (Erembodegem, Belgium). The
biotinylated anti-CD105 and FITC-conjugated anti-CD133 was obtained from
eBioscience (San Diego, CA, USA).
Preparation of neovascularized subcutaneous cavity and
hepatocyte implantation. To induce neovascularization, osmotic pumps
(Alzet, Company, Cupertino, CA, USA) filled with 10 mg of bFGF and 0.1 mg of
heparin in 100ml were implanted into the subcutaneous space on the back of Nu/Nu
nude mice (Charles-River Laboratories, Lecco, Italy). Ten days after implantation,
when the subcutaneous tissues around the device were efficiently neovascularized,
the pumps were removed. Immediately after the removal of the device, 1 106
RLSCs, resuspended in an equal mixture of HC medium and Matrigel (BD,
Bioscience), were implanted into the subcutaneous pocket. Mice were killed 30 days
after cell transplantation and the engineered tissues removed, mounted onto OCT,
frozen in liquid propane and cooled by liquid nitrogen. The histological slides were
immunostained for Albumin (rabbit polyclonal anti-Albumin, Novus-Biologicals) and
cyto-keratin-7 (AbCam, Cambridge, UK).
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